Ralph S. Baric
#47,157
Most Influential Person Now
American researcher and epidemiologist
Ralph S. Baric's AcademicInfluence.com Rankings
Ralph S. Baricmedical Degrees
Medical
#529
World Rank
#717
Historical Rank
#203
USA Rank
Epidemiology
#63
World Rank
#71
Historical Rank
#18
USA Rank
Ralph S. Baricbiology Degrees
Biology
#1808
World Rank
#2934
Historical Rank
#864
USA Rank
Virology
#37
World Rank
#39
Historical Rank
#16
USA Rank
Download Badge
Medical Biology
Ralph S. Baric's Degrees
- PhD Microbiology University of North Carolina at Chapel Hill
Why Is Ralph S. Baric Influential?
(Suggest an Edit or Addition)According to Wikipedia, Ralph Steven Baric is William R. Kenan Jr. Distinguished Professor in the Department of Epidemiology, and professor in the Department of Microbiology and Immunology at The University of North Carolina at Chapel Hill.
Ralph S. Baric's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2 (2020) (5195)
- Receptor Recognition by the Novel Coronavirus from Wuhan: an Analysis Based on Decade-Long Structural Studies of SARS Coronavirus (2020) (3366)
- Sharing and community curation of mass spectrometry data with Global Natural Products Social Molecular Networking (2016) (2091)
- Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV (2020) (1524)
- Severe acute respiratory syndrome-related coronavirus: The species and its viruses – a statement of the Coronavirus Study Group (2020) (1373)
- Broad-spectrum antiviral GS-5734 inhibits both epidemic and zoonotic coronaviruses (2017) (1328)
- Antigen-Specific Adaptive Immunity to SARS-CoV-2 in Acute COVID-19 and Associations with Age and Disease Severity (2020) (1215)
- Coronavirus Susceptibility to the Antiviral Remdesivir (GS-5734) Is Mediated by the Viral Polymerase and the Proofreading Exoribonuclease (2018) (1198)
- Norwalk virus: How infectious is it? (2008) (1116)
- Commentary: Middle East Respiratory Syndrome Coronavirus (MERS-CoV): Announcement of the Coronavirus Study Group (2013) (1101)
- SARS-CoV-2 Reverse Genetics Reveals a Variable Infection Gradient in the Respiratory Tract (2020) (1073)
- Human susceptibility and resistance to Norwalk virus infection (2003) (1023)
- Safety and Immunogenicity of SARS-CoV-2 mRNA-1273 Vaccine in Older Adults (2020) (1020)
- DNA vaccine protection against SARS-CoV-2 in rhesus macaques (2020) (931)
- SARS-CoV-2 mRNA Vaccine Design Enabled by Prototype Pathogen Preparedness (2020) (846)
- Potently neutralizing and protective human antibodies against SARS-CoV-2 (2020) (824)
- Evaluation of the mRNA-1273 Vaccine against SARS-CoV-2 in Nonhuman Primates (2020) (809)
- SARS-CoV-2 infection protects against rechallenge in rhesus macaques (2020) (779)
- A SARS-like cluster of circulating bat coronaviruses shows potential for human emergence (2015) (767)
- An orally bioavailable broad-spectrum antiviral inhibits SARS-CoV-2 in human airway epithelial cell cultures and multiple coronaviruses in mice (2020) (752)
- Single-Shot Ad26 Vaccine Protects Against SARS-CoV-2 in Rhesus Macaques (2020) (736)
- Zn2+ Inhibits Coronavirus and Arterivirus RNA Polymerase Activity In Vitro and Zinc Ionophores Block the Replication of These Viruses in Cell Culture (2010) (718)
- SARS-CoV-2 D614G variant exhibits efficient replication ex vivo and transmission in vivo (2020) (681)
- The receptor binding domain of the viral spike protein is an immunodominant and highly specific target of antibodies in SARS-CoV-2 patients (2020) (664)
- A decade after SARS: strategies for controlling emerging coronaviruses (2013) (630)
- Severe Acute Respiratory Syndrome Coronavirus Open Reading Frame (ORF) 3b, ORF 6, and Nucleocapsid Proteins Function as Interferon Antagonists (2006) (620)
- Recombination, Reservoirs, and the Modular Spike: Mechanisms of Coronavirus Cross-Species Transmission (2009) (606)
- Coronavirus Genome Structure and Replication (2005) (587)
- Animal models for COVID-19 (2020) (582)
- Complement Activation Contributes to Severe Acute Respiratory Syndrome Coronavirus Pathogenesis (2018) (561)
- Mechanisms of GII.4 Norovirus Persistence in Human Populations (2008) (526)
- Severe Acute Respiratory Syndrome Coronavirus ORF6 Antagonizes STAT1 Function by Sequestering Nuclear Import Factors on the Rough Endoplasmic Reticulum/Golgi Membrane (2007) (479)
- Broad neutralization of SARS-related viruses by human monoclonal antibodies (2020) (464)
- Receptor recognition by novel coronavirus from Wuhan: 2 An analysis based on decade-long structural studies of SARS 3 (2020) (452)
- A Double-Inactivated Severe Acute Respiratory Syndrome Coronavirus Vaccine Provides Incomplete Protection in Mice and Induces Increased Eosinophilic Proinflammatory Pulmonary Response upon Challenge (2011) (436)
- Pathogenesis of SARS-CoV-2 in Transgenic Mice Expressing Human Angiotensin-Converting Enzyme 2 (2020) (432)
- A mouse-adapted model of SARS-CoV-2 to test COVID-19 countermeasures (2020) (424)
- Rapid generation of a mouse model for Middle East respiratory syndrome (2014) (419)
- Coronaviruses: an RNA proofreading machine regulates replication fidelity and diversity. (2011) (417)
- The Genome Architecture of the Collaborative Cross Mouse Genetic Reference Population (2012) (416)
- Airway Memory CD4+ T Cells Mediate Protective Immunity against Emerging Respiratory Coronaviruses (2016) (415)
- A Mouse-Adapted SARS-Coronavirus Causes Disease and Mortality in BALB/c Mice (2007) (413)
- Broad spectrum antiviral remdesivir inhibits human endemic and zoonotic deltacoronaviruses with a highly divergent RNA dependent RNA polymerase (2019) (401)
- Infidelity of SARS-CoV Nsp14-Exonuclease Mutant Virus Replication Is Revealed by Complete Genome Sequencing (2010) (393)
- SARS coronavirus pathogenesis: host innate immune responses and viral antagonism of interferon (2012) (382)
- Reverse genetics with a full-length infectious cDNA of severe acute respiratory syndrome coronavirus (2003) (365)
- Toll-Like Receptor 3 Signaling via TRIF Contributes to a Protective Innate Immune Response to Severe Acute Respiratory Syndrome Coronavirus Infection (2015) (364)
- Identification of human neutralizing antibodies that bind to complex epitopes on dengue virions (2012) (355)
- Coronaviruses (2011) (354)
- SARS-like WIV1-CoV poised for human emergence (2016) (350)
- Remdesivir Inhibits SARS-CoV-2 in Human Lung Cells and Chimeric SARS-CoV Expressing the SARS-CoV-2 RNA Polymerase in Mice (2020) (347)
- A Mouse-Adapted SARS-CoV-2 Induces Acute Lung Injury and Mortality in Standard Laboratory Mice (2020) (346)
- A Single-Dose Intranasal ChAd Vaccine Protects Upper and Lower Respiratory Tracts against SARS-CoV-2 (2020) (340)
- Genetic analysis of complex traits in the emerging Collaborative Cross. (2011) (333)
- Human Papillomavirus and head and neck cancer: Epidemiology and molecular biology (1998) (329)
- Durability of mRNA-1273 vaccine–induced antibodies against SARS-CoV-2 variants (2021) (322)
- Systematic Assembly of a Full-Length Infectious cDNA of Mouse Hepatitis Virus Strain A59 (2002) (320)
- Severe Acute Respiratory Syndrome Coronavirus Infection of Human Ciliated Airway Epithelia: Role of Ciliated Cells in Viral Spread in the Conducting Airways of the Lungs (2005) (318)
- Severe Acute Respiratory Syndrome Coronavirus Evades Antiviral Signaling: Role of nsp1 and Rational Design of an Attenuated Strain (2007) (311)
- Molecular pathology of emerging coronavirus infections (2014) (292)
- Potent cross-reactive neutralization of SARS coronavirus isolates by human monoclonal antibodies (2007) (281)
- Further Evidence for Bats as the Evolutionary Source of Middle East Respiratory Syndrome Coronavirus (2017) (277)
- The neutralizing antibody, LY-CoV555, protects against SARS-CoV-2 infection in nonhuman primates (2021) (270)
- Binding of Norwalk Virus-Like Particles to ABH Histo-Blood Group Antigens Is Blocked by Antisera from Infected Human Volunteers or Experimentally Vaccinated Mice (2002) (268)
- Norovirus Infectivity in Humans and Persistence in Water (2011) (267)
- Severe Acute Respiratory Syndrome Coronavirus Group-Specific Open Reading Frames Encode Nonessential Functions for Replication in Cell Cultures and Mice (2005) (267)
- Cell Host Response to Infection with Novel Human Coronavirus EMC Predicts Potential Antivirals and Important Differences with SARS Coronavirus (2013) (265)
- Vaccine Efficacy in Senescent Mice Challenged with Recombinant SARS-CoV Bearing Epidemic and Zoonotic Spike Variants (2006) (265)
- Reverse genetics with a full-length infectious cDNA of the Middle East respiratory syndrome coronavirus (2013) (264)
- Viral shape-shifting: norovirus evasion of the human immune system (2010) (263)
- Severe Acute Respiratory Syndrome Coronavirus Papain-Like Protease Ubiquitin-Like Domain and Catalytic Domain Regulate Antagonism of IRF3 and NF-κB Signaling (2009) (260)
- Mechanisms of Severe Acute Respiratory Syndrome Coronavirus-Induced Acute Lung Injury (2013) (260)
- Cellular and Humoral Immunity following Snow Mountain Virus Challenge (2005) (257)
- Evidence Supporting a Zoonotic Origin of Human Coronavirus Strain NL63 (2012) (254)
- Norovirus pathogenesis: mechanisms of persistence and immune evasion in human populations (2008) (252)
- Synthetic recombinant bat SARS-like coronavirus is infectious in cultured cells and in mice (2008) (251)
- Immunogenetic Mechanisms Driving Norovirus GII.4 Antigenic Variation (2012) (249)
- Host genetic diversity enables Ebola hemorrhagic fever pathogenesis and resistance (2014) (249)
- Strategy for Systematic Assembly of Large RNA and DNA Genomes: Transmissible Gastroenteritis Virus Model (2000) (246)
- Pathogenic Influenza Viruses and Coronaviruses Utilize Similar and Contrasting Approaches To Control Interferon-Stimulated Gene Responses (2014) (245)
- Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein (2020) (241)
- Antibody potency, effector function, and combinations in protection and therapy for SARS-CoV-2 infection in vivo (2020) (236)
- Identification of human neutralizing antibodies against MERS-CoV and their role in virus adaptive evolution (2014) (234)
- SARS-CoV-2 Infection is Effectively Treated and Prevented by EIDD-2801 (2021) (233)
- Immunogenicity of Ad26.COV2.S vaccine against SARS-CoV-2 variants in humans (2021) (232)
- Unique Signatures of Long Noncoding RNA Expression in Response to Virus Infection and Altered Innate Immune Signaling (2010) (231)
- Analysis of Intraviral Protein-Protein Interactions of the SARS Coronavirus ORFeome (2007) (230)
- SARS coronavirus and innate immunity (2007) (229)
- Receptor usage and cell entry of bat coronavirus HKU4 provide insight into bat-to-human transmission of MERS coronavirus (2014) (228)
- Broad and potent activity against SARS-like viruses by an engineered human monoclonal antibody (2021) (219)
- Severe acute respiratory syndrome-related coronavirus: The species and its viruses – a statement of the Coronavirus Study Group (2020) (218)
- A live, impaired-fidelity coronavirus vaccine protects in an aged, immunocompromised mouse model of lethal disease (2012) (218)
- Recombination between nonsegmented RNA genomes of murine coronaviruses (1985) (217)
- Dengue Virus Envelope Dimer Epitope Monoclonal Antibodies Isolated from Dengue Patients Are Protective against Zika Virus (2016) (213)
- Prophylactic and postexposure efficacy of a potent human monoclonal antibody against MERS coronavirus (2015) (209)
- Elicitation of Potent Neutralizing Antibody Responses by Designed Protein Nanoparticle Vaccines for SARS-CoV-2 (2020) (207)
- In-Depth Analysis of the Antibody Response of Individuals Exposed to Primary Dengue Virus Infection (2011) (207)
- Human Coronavirus HKU1 Spike Protein Uses O-Acetylated Sialic Acid as an Attachment Receptor Determinant and Employs Hemagglutinin-Esterase Protein as a Receptor-Destroying Enzyme (2015) (201)
- Human Lung Stem Cell-Based Alveolospheres Provide Insights into SARS-CoV-2-Mediated Interferon Responses and Pneumocyte Dysfunction (2020) (198)
- Characterization of leader RNA sequences on the virion and mRNAs of mouse hepatitis virus, a cytoplasmic RNA virus. (1984) (196)
- Attenuation and Restoration of Severe Acute Respiratory Syndrome Coronavirus Mutant Lacking 2′-O-Methyltransferase Activity (2014) (196)
- Elicitation of potent neutralizing antibody responses by designed protein nanoparticle vaccines for SARS-CoV-2 (2020) (195)
- Small-Molecule Antiviral β-d-N4-Hydroxycytidine Inhibits a Proofreading-Intact Coronavirus with a High Genetic Barrier to Resistance (2019) (194)
- Progenitor identification and SARS-CoV-2 infection in human distal lung organoids (2020) (186)
- Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein (2020) (186)
- Specific interaction between coronavirus leader RNA and nucleocapsid protein (1988) (183)
- Interactions between coronavirus nucleocapsid protein and viral RNAs: implications for viral transcription (1988) (182)
- The nsp2 Replicase Proteins of Murine Hepatitis Virus and Severe Acute Respiratory Syndrome Coronavirus Are Dispensable for Viral Replication (2005) (178)
- A mouse model for MERS coronavirus-induced acute respiratory distress syndrome (2016) (178)
- MyD88 Is Required for Protection from Lethal Infection with a Mouse-Adapted SARS-CoV (2008) (176)
- Modeling Host Genetic Regulation of Influenza Pathogenesis in the Collaborative Cross (2013) (176)
- An Immunocompetent Mouse Model of Zika Virus Infection. (2018) (175)
- In vitro and in vivo functions of SARS-CoV-2 infection-enhancing and neutralizing antibodies (2021) (175)
- Genomic RNA Elements Drive Phase Separation of the SARS-CoV-2 Nucleocapsid (2020) (173)
- Tropism of and Innate Immune Responses to the Novel Human Betacoronavirus Lineage C Virus in Human Ex Vivo Respiratory Organ Cultures (2013) (170)
- Detection of Norwalk virus in stool specimens by reverse transcriptase-polymerase chain reaction and nonradioactive oligoprobes (1992) (165)
- β-d-N4-hydroxycytidine Inhibits SARS-CoV-2 Through Lethal Mutagenesis But Is Also Mutagenic To Mammalian Cells (2021) (161)
- A strong association between mefloquine and halofantrine resistance and amplification, overexpression, and mutation in the P-glycoprotein gene homolog (pfmdr) of Plasmodium falciparum in vitro. (1994) (158)
- Emergence of new pandemic GII.4 Sydney norovirus strain correlates with escape from herd immunity. (2013) (158)
- Norovirus GII.4 Strain Antigenic Variation (2010) (157)
- Trypsin Treatment Unlocks Barrier for Zoonotic Bat Coronavirus Infection (2019) (154)
- Differential Kinetics of Immune Responses Elicited by Covid-19 Vaccines (2021) (154)
- Characterization of replicative intermediate RNA of mouse hepatitis virus: presence of leader RNA sequences on nascent chains (1983) (154)
- Structural Basis for Potent Cross-Neutralizing Human Monoclonal Antibody Protection against Lethal Human and Zoonotic Severe Acute Respiratory Syndrome Coronavirus Challenge (2008) (152)
- Neutralizing antibody vaccine for pandemic and pre-emergent coronaviruses (2021) (152)
- SARS-CoV and emergent coronaviruses: viral determinants of interspecies transmission (2011) (151)
- Molnupiravir, an Oral Antiviral Treatment for COVID-19 (2021) (151)
- Prevalent, protective, and convergent IgG recognition of SARS-CoV-2 non-RBD spike epitopes (2021) (150)
- Genetic Mapping of a Highly Variable Norovirus GII.4 Blockade Epitope: Potential Role in Escape from Human Herd Immunity (2011) (149)
- Multivalent norovirus vaccines induce strong mucosal and systemic blocking antibodies against multiple strains. (2006) (147)
- Heterologous Gene Expression from Transmissible Gastroenteritis Virus Replicon Particles (2002) (147)
- Emergence of a Norovirus GII.4 Strain Correlates with Changes in Evolving Blockade Epitopes (2012) (145)
- SARS-CoV Pathogenesis Is Regulated by a STAT1 Dependent but a Type I, II and III Interferon Receptor Independent Mechanism (2010) (143)
- A phase 2a clinical trial of molnupiravir in patients with COVID-19 shows accelerated SARS-CoV-2 RNA clearance and elimination of infectious virus (2021) (143)
- Establishing a genetic recombination map for murine coronavirus strain A59 complementation groups (1990) (143)
- Heterotypic Humoral and Cellular Immune Responses following Norwalk Virus Infection (2009) (140)
- Norovirus Capture with Histo-Blood Group Antigens Reveals Novel Virus-Ligand Interactions (2004) (140)
- A new mouse-adapted strain of SARS-CoV as a lethal model for evaluating antiviral agents in vitro and in vivo (2009) (140)
- Animal models and vaccines for SARS-CoV infection (2007) (139)
- Emergence of a Highly Fit SARS-CoV-2 Variant. (2020) (138)
- Presence of leader sequences in the mRNA of mouse hepatitis virus (1983) (137)
- MERS-CoV and H5N1 influenza virus antagonize antigen presentation by altering the epigenetic landscape (2018) (137)
- Culturing the Unculturable: Human Coronavirus HKU1 Infects, Replicates, and Produces Progeny Virions in Human Ciliated Airway Epithelial Cell Cultures (2010) (137)
- Molecular Determinants of Severe Acute Respiratory Syndrome Coronavirus Pathogenesis and Virulence in Young and Aged Mouse Models of Human Disease (2011) (137)
- Natural Strain Variation and Antibody Neutralization of Dengue Serotype 3 Viruses (2010) (136)
- MPLEx: a Robust and Universal Protocol for Single-Sample Integrative Proteomic, Metabolomic, and Lipidomic Analyses (2016) (136)
- Ultrapotent antibodies against diverse and highly transmissible SARS-CoV-2 variants (2021) (133)
- Detection of norwalk-like virus in shellfish implicated in illness. (2000) (130)
- Lack of Durable Cross-Neutralizing Antibodies Against Zika Virus from Dengue Virus Infection (2017) (129)
- SARS-CoV-2 mRNA Vaccine Development Enabled by Prototype Pathogen Preparedness (2020) (128)
- Crystal Structure of the Receptor-Binding Domain from Newly Emerged Middle East Respiratory Syndrome Coronavirus (2013) (128)
- Genome Wide Identification of SARS-CoV Susceptibility Loci Using the Collaborative Cross (2015) (128)
- LY-CoV555, a rapidly isolated potent neutralizing antibody, provides protection in a non-human primate model of SARS-CoV-2 infection (2020) (127)
- Norovirus Immunity and the Great Escape (2012) (124)
- Mechanisms of Zoonotic Severe Acute Respiratory Syndrome Coronavirus Host Range Expansion in Human Airway Epithelium (2007) (123)
- De novo design of potent and resilient hACE2 decoys to neutralize SARS-CoV-2 (2020) (123)
- Jumping species—a mechanism for coronavirus persistence and survival (2017) (123)
- Release of Severe Acute Respiratory Syndrome Coronavirus Nuclear Import Block Enhances Host Transcription in Human Lung Cells (2013) (121)
- MERS-CoV Accessory ORFs Play Key Role for Infection and Pathogenesis (2017) (119)
- A Live Attenuated Severe Acute Respiratory Syndrome Coronavirus Is Immunogenic and Efficacious in Golden Syrian Hamsters (2008) (118)
- Agricultural risk factors for t(14;18) subtypes of non-Hodgkin’s lymphoma (2001) (118)
- Monoclonal Antibody-Based Antigenic Mapping of Norovirus GII.4-2002 (2011) (117)
- Structure of mouse coronavirus spike protein complexed with receptor reveals mechanism for viral entry (2020) (117)
- Middle East Respiratory Syndrome Coronavirus NS4b Protein Inhibits Host RNase L Activation (2016) (116)
- Broad Blockade Antibody Responses in Human Volunteers after Immunization with a Multivalent Norovirus VLP Candidate Vaccine: Immunological Analyses from a Phase I Clinical Trial (2015) (115)
- Two Mutations Were Critical for Bat-to-Human Transmission of Middle East Respiratory Syndrome Coronavirus (2015) (115)
- Possibility for reverse zoonotic transmission of SARS-CoV-2 to free-ranging wildlife: A case study of bats (2020) (113)
- Systemic, Mucosal, and Heterotypic Immune Induction in Mice Inoculated with Venezuelan Equine Encephalitis Replicons Expressing Norwalk Virus-Like Particles (2002) (112)
- Vaccines to prevent severe acute respiratory syndrome coronavirus-induced disease (2007) (112)
- Molecular anatomy of mouse hepatitis virus persistence: coevolution of increased host cell resistance and virus virulence (1996) (111)
- Herd Immunity to GII.4 Noroviruses Is Supported by Outbreak Patient Sera (2009) (111)
- Mechanisms of Severe Acute Respiratory Syndrome Pathogenesis and Innate Immunomodulation (2008) (111)
- Immune Mechanisms Responsible for Vaccination against and Clearance of Mucosal and Lymphatic Norovirus Infection (2008) (110)
- Cynomolgus Macaque as an Animal Model for Severe Acute Respiratory Syndrome (2006) (107)
- Episodic evolution mediates interspecies transfer of a murine coronavirus (1997) (105)
- Evaluation of Serologic and Antigenic Relationships Between Middle Eastern Respiratory Syndrome Coronavirus and Other Coronaviruses to Develop Vaccine Platforms for the Rapid Response to Emerging Coronaviruses (2013) (102)
- Consensus summary report for CEPI/BC March 12–13, 2020 meeting: Assessment of risk of disease enhancement with COVID-19 vaccines (2020) (101)
- Congenital Zika Virus Infection as a Silent Pathology With Loss of Neurogenic Output in the Fetal Brain (2018) (100)
- The Open Reading Frame 3a Protein of Severe Acute Respiratory Syndrome-Associated Coronavirus Promotes Membrane Rearrangement and Cell Death (2009) (100)
- Expression and Self-Assembly of Norwalk Virus Capsid Protein from Venezuelan Equine Encephalitis Virus Replicons (2002) (100)
- Early Upregulation of Acute Respiratory Distress Syndrome-Associated Cytokines Promotes Lethal Disease in an Aged-Mouse Model of Severe Acute Respiratory Syndrome Coronavirus Infection (2009) (100)
- Mouse Dipeptidyl Peptidase 4 Is Not a Functional Receptor for Middle East Respiratory Syndrome Coronavirus Infection (2014) (100)
- Severe Acute Respiratory Syndrome Coronavirus nsp9 Dimerization Is Essential for Efficient Viral Growth (2009) (96)
- Single-Amino-Acid Substitutions in Open Reading Frame (ORF) 1b-nsp14 and ORF 2a Proteins of the Coronavirus Mouse Hepatitis Virus Are Attenuating in Mice (2005) (96)
- Antibody Is Critical for the Clearance of Murine Norovirus Infection (2008) (96)
- A mouse-adapted SARS-CoV-2 model for the evaluation of COVID-19 medical countermeasures (2020) (96)
- Characterization of leader-related small RNAs in coronavirus-infected cells: Further evidence for leader-primed mechanism of transcription (1985) (96)
- Early Upregulation of Acute Respiratory Distress Syndrome-Associated Cytokines Promotes Lethal Disease in an Aged-Mouse Model of Severe Acute Respiratory Syndrome Coronavirus Infection (2009) (96)
- Chimeric spike mRNA vaccines protect against Sarbecovirus challenge in mice (2021) (95)
- Middle East Respiratory Syndrome Coronavirus Nonstructural Protein 16 Is Necessary for Interferon Resistance and Viral Pathogenesis (2017) (95)
- Escape from Human Monoclonal Antibody Neutralization Affects In Vitro and In Vivo Fitness of Severe Acute Respiratory Syndrome Coronavirus (2010) (94)
- A Method To Detect Low Levels of Enteric Viruses in Contaminated Oysters (1999) (94)
- Processing of Open Reading Frame 1a Replicase Proteins nsp7 to nsp10 in Murine Hepatitis Virus Strain A59 Replication (2007) (93)
- Coronavirus non-structural protein 16: Evasion, attenuation, and possible treatments (2014) (92)
- Dissecting Antibodies Induced by a Chimeric Yellow Fever–Dengue, Live-Attenuated, Tetravalent Dengue Vaccine (CYD-TDV) in Naive and Dengue-Exposed Individuals (2016) (92)
- Epigenetic Landscape during Coronavirus Infection (2017) (91)
- Persistent Infection Promotes Cross-Species Transmissibility of Mouse Hepatitis Virus (1999) (91)
- Novel Influenza Virus NS1 Antagonists Block Replication and Restore Innate Immune Function (2008) (90)
- High Potency of a Bivalent Human VH Domain in SARS-CoV-2 Animal Models (2020) (89)
- Systematic Assembly of a Full-Length Infectious Clone of Human Coronavirus NL63 (2008) (89)
- Annotation of long non-coding RNAs expressed in Collaborative Cross founder mice in response to respiratory virus infection reveals a new class of interferon-stimulated transcripts (2014) (88)
- Investigate the origins of COVID-19 (2021) (88)
- Sharing and community curation of mass spectrometry data with GNPS (2016) (87)
- Subgenomic Negative-Strand RNA Function during Mouse Hepatitis Virus Infection (2000) (87)
- Neutralization mechanism of a highly potent antibody against Zika virus (2016) (86)
- The Current and Future State of Vaccines, Antivirals and Gene Therapies Against Emerging Coronaviruses (2020) (85)
- Expression Quantitative Trait Loci for Extreme Host Response to Influenza A in Pre-Collaborative Cross Mice (2012) (84)
- Integrative Deep Sequencing of the Mouse Lung Transcriptome Reveals Differential Expression of Diverse Classes of Small RNAs in Response to Respiratory Virus Infection (2011) (84)
- Development and Characterization of a Reverse Genetic System for Studying Dengue Virus Serotype 3 Strain Variation and Neutralization (2012) (82)
- Rewiring the severe acute respiratory syndrome coronavirus (SARS-CoV) transcription circuit: Engineering a recombination-resistant genome (2006) (82)
- Developing therapeutic approaches for twenty-first-century emerging infectious viral diseases (2021) (80)
- What Is the Reservoir of Emergent Human Norovirus Strains? (2015) (80)
- Fc-engineered antibody therapeutics with improved anti-SARS-CoV-2 efficacy (2021) (79)
- Coronavirus Host Range Expansion and Middle East Respiratory Syndrome Coronavirus Emergence: Biochemical Mechanisms and Evolutionary Perspectives. (2015) (79)
- Molecular Surveillance of Enterovirus and Norwalk-Like Virus in Oysters Relocated to a Municipal-Sewage-Impacted Gulf Estuary (2003) (78)
- Alphavirus-Adjuvanted Norovirus-Like Particle Vaccines: Heterologous, Humoral, and Mucosal Immune Responses Protect against Murine Norovirus Challenge (2009) (76)
- A New Quaternary Structure Epitope on Dengue Virus Serotype 2 Is the Target of Durable Type-Specific Neutralizing Antibodies (2015) (75)
- Specificity and kinetics of norovirus binding to magnetic bead‐conjugated histo‐blood group antigens (2010) (75)
- Characterization of the homo‐ and heterotypic immune responses after natural norovirus infection (2005) (75)
- A Network Integration Approach to Predict Conserved Regulators Related to Pathogenicity of Influenza and SARS-CoV Respiratory Viruses (2013) (75)
- Successful Vaccination Strategies That Protect Aged Mice from Lethal Challenge from Influenza Virus and Heterologous Severe Acute Respiratory Syndrome Coronavirus (2010) (75)
- Antagonism of dsRNA-Induced Innate Immune Pathways by NS4a and NS4b Accessory Proteins during MERS Coronavirus Infection (2019) (74)
- Genetics of mouse hepatitis virus transcription: evidence that subgenomic negative strands are functional templates (1994) (74)
- Vaccination-induced herd immunity: Successes and challenges. (2018) (73)
- Swine acute diarrhea syndrome coronavirus replication in primary human cells reveals potential susceptibility to infection (2020) (73)
- Improved quality control processing of peptide-centric LC-MS proteomics data (2011) (73)
- Envelope Protein Glycosylation Mediates Zika Virus Pathogenesis (2019) (73)
- Pathways of Cross-Species Transmission of Synthetically Reconstructed Zoonotic Severe Acute Respiratory Syndrome Coronavirus (2008) (71)
- Rapid identification of a human antibody with high prophylactic and therapeutic efficacy in three animal models of SARS-CoV-2 infection (2020) (71)
- Sindbis virus mutants selected for rapid growth in cell culture display attenuated virulence in animals. (1984) (70)
- Effects of Human Anti-Spike Protein Receptor Binding Domain Antibodies on Severe Acute Respiratory Syndrome Coronavirus Neutralization Escape and Fitness (2014) (70)
- Comparison of Subgenomic and Total RNA in SARS-CoV-2-Challenged Rhesus Macaques (2021) (69)
- Characterization of a Pathogenic Full-Length cDNA Clone and Transmission Model for Porcine Epidemic Diarrhea Virus Strain PC22A (2016) (69)
- 3B11-N, a monoclonal antibody against MERS-CoV, reduces lung pathology in rhesus monkeys following intratracheal inoculation of MERS-CoV Jordan-n3/2012 (2016) (67)
- Allelic Variation in the Toll-Like Receptor Adaptor Protein Ticam2 Contributes to SARS-Coronavirus Pathogenesis in Mice (2017) (67)
- The state of norovirus vaccines. (2014) (67)
- A Mouse Model for Betacoronavirus Subgroup 2c Using a Bat Coronavirus Strain HKU5 Variant (2014) (66)
- Newcastle disease virus (NDV) expressing the spike protein of SARS-CoV-2 as a live virus vaccine candidate (2020) (66)
- Synthetic Reconstruction of Zoonotic and Early Human Severe Acute Respiratory Syndrome Coronavirus Isolates That Produce Fatal Disease in Aged Mice (2007) (65)
- The functions of SARS-CoV-2 neutralizing and infection-enhancing antibodies in vitro and in mice and nonhuman primates (2021) (65)
- Dengue virus envelope protein domain I/II hinge determines long-lived serotype-specific dengue immunity (2014) (64)
- Deletion of the SARS-CoV-2 Spike Cytoplasmic Tail Increases Infectivity in Pseudovirus Neutralization Assays (2021) (63)
- Characterization of Emerging GII.g/GII.12 Noroviruses from a Gastroenteritis Outbreak in the United States in 2010 (2011) (62)
- Saracatinib Inhibits Middle East Respiratory Syndrome-Coronavirus Replication In Vitro (2018) (62)
- Detection of low levels of enteric viruses in metropolitan and airplane sewage (1997) (61)
- Combination Attenuation Offers Strategy for Live Attenuated Coronavirus Vaccines (2018) (61)
- Maternally Acquired Zika Antibodies Enhance Dengue Disease Severity in Mice. (2018) (61)
- A Reverse Genetics Platform That Spans the Zika Virus Family Tree (2017) (59)
- Altering SARS Coronavirus Frameshift Efficiency Affects Genomic and Subgenomic RNA Production (2013) (59)
- Persistent Replication of Severe Acute Respiratory Syndrome Coronavirus in Human Tubular Kidney Cells Selects for Adaptive Mutations in the Membrane Protein (2008) (59)
- Sera Antibody Repertoire Analyses Reveal Mechanisms of Broad and Pandemic Strain Neutralizing Responses after Human Norovirus Vaccination (2019) (59)
- Precision mouse models with expanded tropism for human pathogens (2019) (58)
- Deletion of a 197-Amino-Acid Region in the N-Terminal Domain of Spike Protein Attenuates Porcine Epidemic Diarrhea Virus in Piglets (2017) (58)
- Defining the risk of SARS-CoV-2 variants on immune protection (2022) (58)
- Remdesivir potently inhibits SARS-CoV-2 in human lung cells and chimeric SARS-CoV expressing the SARS-CoV-2 RNA polymerase in mice (2020) (58)
- A broadly cross-reactive antibody neutralizes and protects against sarbecovirus challenge in mice (2021) (58)
- Within-Host Evolution Results in Antigenically Distinct GII.4 Noroviruses (2014) (58)
- The effect of inhibition of PP1 and TNFα signaling on pathogenesis of SARS coronavirus (2016) (58)
- Analysis of intracellular small RNAs of mouse hepatitis virus: evidence for discontinuous transcription (1987) (57)
- Glycosylation of Mouse DPP4 Plays a Role in Inhibiting Middle East Respiratory Syndrome Coronavirus Infection (2015) (56)
- Elicitation of broadly protective sarbecovirus immunity by receptor-binding domain nanoparticle vaccines (2021) (56)
- Evidence for variable rates of recombination in the MHV genome (1992) (55)
- Lysosomal Proteases Are a Determinant of Coronavirus Tropism (2018) (53)
- Map locations of mouse hepatitis virus temperature-sensitive mutants: confirmation of variable rates of recombination (1994) (53)
- Analysis of Murine Hepatitis Virus Strain A59 Temperature-Sensitive Mutant TS-LA6 Suggests that nsp10 Plays a Critical Role in Polyprotein Processing (2007) (53)
- Elicitation of broadly protective sarbecovirus immunity by receptor-binding domain nanoparticle vaccines (2021) (52)
- Murine Hepatitis Virus Replicase Protein nsp10 Is a Critical Regulator of Viral RNA Synthesis (2007) (52)
- New Metrics for Evaluating Viral Respiratory Pathogenesis (2015) (52)
- Potent neutralization of SARS-CoV-2 by human antibody heavy-chain variable domains isolated from a large library with a new stable scaffold (2020) (52)
- Particle Conformation Regulates Antibody Access to a Conserved GII.4 Norovirus Blockade Epitope (2014) (51)
- RNA dimerization plays a role in ribosomal frameshifting of the SARS coronavirus (2012) (51)
- A highly immunogenic and effective measles virus-based Th1-biased COVID-19 vaccine (2020) (50)
- Cleavage between Replicase Proteins p28 and p65 of Mouse Hepatitis Virus Is Not Required for Virus Replication (2004) (50)
- An orally bioavailable broad-spectrum antiviral inhibits SARS-CoV-2 and multiple endemic, epidemic and bat coronavirus (2020) (50)
- Potently neutralizing human antibodies that block SARS-CoV-2 receptor binding and protect animals (2020) (50)
- Development and deployment of COVID-19 vaccines for those most vulnerable (2021) (49)
- Evaluation of Cell-Based and Surrogate SARS-CoV-2 Neutralization Assays (2021) (49)
- Mutations in the SARS-CoV-2 RNA dependent RNA polymerase confer resistance to remdesivir by distinct mechanisms (2022) (49)
- Specific viral RNA drives the SARS CoV-2 nucleocapsid to phase separate (2020) (49)
- Optimization of non-coding regions for a non-modified mRNA COVID-19 vaccine (2021) (48)
- SARS-CoV-2 D614G Variant Exhibits Enhanced Replication ex vivo and Earlier Transmission in vivo (2020) (48)
- RNA Populations in Immunocompromised Patients as Reservoirs for Novel Norovirus Variants (2014) (47)
- Genetics of mouse hepatitis virus transcription: Identification of cistrons which may function in positive and negative strand RNA synthesis (1990) (47)
- Genomic diversity of “Norwalk like viruses” (NLVs): Pediatric infections in a Brazilian shantytown (1999) (47)
- Mapping the Human Memory B Cell and Serum Neutralizing Antibody Responses to Dengue Virus Serotype 4 Infection and Vaccination (2016) (46)
- Prevalent, protective, and convergent IgG recognition of SARS-CoV-2 non-RBD spike epitopes in COVID-19 convalescent plasma (2020) (46)
- Cryo-electron Microscopy and Exploratory Antisense Targeting of the 28-kDa Frameshift Stimulation Element from the SARS-CoV-2 RNA Genome (2020) (46)
- Cross-reactive coronavirus antibodies with diverse epitope specificities and Fc effector functions (2021) (46)
- Adaptive evolution influences the infectious dose of MERS-CoV necessary to achieve severe respiratory disease (2017) (45)
- Evaluation of a recombination-resistant coronavirus as a broadly applicable, rapidly implementable vaccine platform (2018) (45)
- Cryo-EM and antisense targeting of the 28-kDa frameshift stimulation element from the SARS-CoV-2 RNA genome (2020) (45)
- Bugs in the system (2013) (44)
- An Experimental Model for Myocarditis and Congestive Heart Failure after Rabbit Coronavirus Infection (1992) (44)
- Derivation of highly mefloquine-resistant lines from Plasmodium falciparum in vitro. (1993) (43)
- Transcriptomic Analysis Reveals a Mechanism for a Prefibrotic Phenotype in STAT1 Knockout Mice during Severe Acute Respiratory Syndrome Coronavirus Infection (2010) (43)
- A comprehensive collection of systems biology data characterizing the host response to viral infection (2014) (43)
- High-Density Amplicon Sequencing Identifies Community Spread and Ongoing Evolution of SARS-CoV-2 in the Southern United States (2020) (43)
- Genetic Variation between Dengue Virus Type 4 Strains Impacts Human Antibody Binding and Neutralization (2018) (42)
- Human coronaviruses and other respiratory infections in young adults on a university campus: Prevalence, symptoms, and shedding (2018) (41)
- Amino Acid Substitutions in the S2 Subunit of Mouse Hepatitis Virus Variant V51 Encode Determinants of Host Range Expansion (2007) (40)
- mRNA Display Design of Fibronectin-based Intrabodies That Detect and Inhibit Severe Acute Respiratory Syndrome Coronavirus Nucleocapsid Protein* (2009) (40)
- Stabilized coronavirus spike stem elicits a broadly protective antibody (2021) (39)
- The nsp1, nsp13, and M Proteins Contribute to the Hepatotropism of Murine Coronavirus JHM.WU (2015) (39)
- An Experimental Model for Dilated Cardiomyopathy after Rabbit Coronavirus Infection (1992) (38)
- Conformational Occlusion of Blockade Antibody Epitopes, a Novel Mechanism of GII.4 Human Norovirus Immune Evasion (2018) (38)
- A Newcastle disease virus (NDV) expressing membrane-anchored spike as a cost-effective inactivated SARS-CoV-2 vaccine (2020) (37)
- Yeast Based Small Molecule Screen for Inhibitors of SARS-CoV (2011) (37)
- COVID-19 vaccine mRNA-1273 elicits a protective immune profile in mice that is not associated with vaccine-enhanced disease upon SARS-CoV-2 challenge (2021) (36)
- Detection of hepatitis A virus and other enteroviruses in water by ssRNA probes. (1991) (36)
- GII.4 Human Norovirus: Surveying the Antigenic Landscape (2019) (36)
- Protective efficacy of Ad26.COV2.S against SARS-CoV-2 B.1.351 in macaques (2021) (36)
- Global Burden of Norovirus and Prospects for Vaccine Development (2015) (36)
- Therapeutic treatment with an oral prodrug of the remdesivir parental nucleoside is protective against SARS-CoV-2 pathogenesis in mice (2022) (35)
- In Vitro Assembly and Stabilization of Dengue and Zika Virus Envelope Protein Homo-Dimers (2017) (35)
- Cytokine systems approach demonstrates differences in innate and pro-inflammatory host responses between genetically distinct MERS-CoV isolates (2014) (35)
- Characterization of Blockade Antibody Responses in GII.2.1976 Snow Mountain Virus-Infected Subjects (2013) (35)
- Emerging human coronaviruses--disease potential and preparedness. (2012) (35)
- A broadly neutralizing antibody protects against SARS-CoV, pre-emergent bat CoVs, and SARS-CoV-2 variants in mice (2021) (34)
- The Endonucleolytic RNA Cleavage Function of nsp1 of Middle East Respiratory Syndrome Coronavirus Promotes the Production of Infectious Virus Particles in Specific Human Cell Lines (2018) (34)
- Permissivity of Dipeptidyl Peptidase 4 Orthologs to Middle East Respiratory Syndrome Coronavirus Is Governed by Glycosylation and Other Complex Determinants (2017) (34)
- CD300lf is the primary physiologic receptor of murine norovirus but not human norovirus (2019) (33)
- Identification of Cross-Reactive Norovirus CD4+ T Cell Epitopes (2010) (33)
- Function of a 5'-end genomic RNA mutation that evolves during persistent mouse hepatitis virus infection in vitro (1995) (33)
- Sex disparities and neutralizing antibody durability to SARS-CoV-2 infection in convalescent individuals (2021) (33)
- Chimeric GII.4 Norovirus Virus-Like-Particle-Based Vaccines Induce Broadly Blocking Immune Responses (2014) (32)
- Comparative analysis of coronavirus genomic RNA structure reveals conservation in SARS-like coronaviruses (2020) (32)
- A Newcastle Disease Virus (NDV) Expressing a Membrane-Anchored Spike as a Cost-Effective Inactivated SARS-CoV-2 Vaccine (2020) (32)
- Functional Transplant of a Dengue Virus Serotype 3 (DENV3)-Specific Human Monoclonal Antibody Epitope into DENV1 (2016) (31)
- Antigenic Variation of the Dengue Virus 2 Genotypes Impacts the Neutralization Activity of Human Antibodies in Vaccinees (2020) (31)
- Requirement for host transcription in the replication of Sindbis virus (1983) (31)
- MPLEx: a method for simultaneous pathogen inactivation and extraction of samples for multi-omics profiling. (2017) (31)
- Effect of Mutations in the Mouse Hepatitis Virus 3′(+)42 Protein Binding Element on RNA Replication (2005) (31)
- Potent neutralization of SARS-CoV-2 in vitro and in an animal model by a human monoclonal antibody (2020) (31)
- Development of a Broadly Accessible Venezuelan Equine Encephalitis Virus Replicon Particle Vaccine Platform (2018) (31)
- Antibody potency, effector function and combinations in protection from SARS-CoV-2 infection in vivo (2020) (30)
- The NSP2 Proteins of Mouse Hepatitis Virus and Sars Coronavirus are Dispensable for Viral Replication (2006) (30)
- Protein co-expression network analysis (ProCoNA) (2013) (30)
- Antibodies with potent and broad neutralizing activity against antigenically diverse and highly transmissible SARS-CoV-2 variants (2021) (29)
- Serum Immunoglobulin A Cross-Strain Blockade of Human Noroviruses (2015) (29)
- Stopping pandemics before they start: Lessons learned from SARS-CoV-2 (2022) (29)
- Progenitor identification and SARS-CoV-2 infection in long-term human distal lung organoid cultures (2020) (29)
- Human Norovirus Detection and Production, Quantification, and Storage of Virus‐Like Particles (2013) (29)
- Development of Mouse Hepatitis Virus and SARS-CoV Infectious cDNA Constructs (2005) (29)
- Expanded subgenomic mRNA transcriptome and coding capacity of a nidovirus (2017) (29)
- Increased Antibody Affinity Confers Broad In Vitro Protection against Escape Mutants of Severe Acute Respiratory Syndrome Coronavirus (2012) (29)
- Emergence of Novel Human Norovirus GII.17 Strains Correlates With Changes in Blockade Antibody Epitopes (2017) (29)
- Human dengue virus serotype 2 neutralizing antibodies target two distinct quaternary epitopes (2018) (29)
- High recombination and mutation rates in mouse hepatitis virus suggest that coronaviruses may be potentially important emerging viruses. (1995) (28)
- Novel virus-like nanoparticle vaccine effectively protects animal model from SARS-CoV-2 infection (2021) (28)
- Antigenic Characterization of a Novel Recombinant GII.P16-GII.4 Sydney Norovirus Strain With Minor Sequence Variation Leading to Antibody Escape (2018) (28)
- Dissecting strategies to tune the therapeutic potential of SARS-CoV-2-specific monoclonal antibody CR3022. (2021) (28)
- Repurposing the Ebola and Marburg Virus Inhibitors Tilorone, Quinacrine, and Pyronaridine: In Vitro Activity against SARS-CoV-2 and Potential Mechanisms (2021) (27)
- Electrocardiographic changes following rabbit coronavirus-induced myocarditis and dilated cardiomyopathy. (1993) (27)
- Hypergraph models of biological networks to identify genes critical to pathogenic viral response (2020) (26)
- Comparative Pathogenesis of Three Human and Zoonotic SARS-CoV Strains in Cynomolgus Macaques (2011) (26)
- SARS-CoV-2: Combating Coronavirus Emergence (2020) (26)
- Evidence for new transcriptional units encoded at the 3' end of the mouse hepatitis virus genome. (1993) (25)
- Broad sarbecovirus neutralizing antibodies define a key site of vulnerability on the SARS-CoV-2 spike protein (2020) (25)
- SARS-CoV-2 infection of airway cells causes intense viral and cell shedding, two spreading mechanisms affected by IL-13 (2022) (25)
- Sequence-Based Classification of Select Agents: A Brighter Line (2010) (25)
- Isolation and identification of six Pneumocystis carinii genes utilizing codon bias. (1993) (24)
- Chimeric spike mRNA vaccines protect against Sarbecovirus challenge in mice (2021) (24)
- Evaluation of SARS-CoV-2 neutralization assays for antibody monitoring in natural infection and vaccine trials (2020) (24)
- A Sindbis virus variant with a cell-determined latent period. (1981) (24)
- The RBD Of The Spike Protein Of SARS-Group Coronaviruses Is A Highly Specific Target Of SARS-CoV-2 Antibodies But Not Other Pathogenic Human and Animal Coronavirus Antibodies (2020) (23)
- A tetravalent live attenuated dengue virus vaccine stimulates balanced immunity to multiple serotypes in humans (2021) (23)
- Giving the Genes a Shuffle: Using Natural Variation to Understand Host Genetic Contributions to Viral Infections (2018) (23)
- Content and Performance of the MiniMUGA Genotyping Array: A New Tool To Improve Rigor and Reproducibility in Mouse Research (2020) (23)
- Targeted isolation of diverse human protective broadly neutralizing antibodies against SARS-like viruses (2022) (23)
- Prevention and therapy of SARS-CoV-2 and the B.1.351 variant in mice (2021) (23)
- Genomic Profiling of Collaborative Cross Founder Mice Infected with Respiratory Viruses Reveals Novel Transcripts and Infection-Related Strain-Specific Gene and Isoform Expression (2014) (23)
- Host-derived intracellular immunization against mouse hepatitis virus infection. (1997) (22)
- Human Norovirus Epitope D Plasticity Allows Escape from Antibody Immunity without Loss of Capacity for Binding Cellular Ligands (2018) (22)
- Multi-omic network signatures of disease (2013) (22)
- Structure, Expression, and Intracellular Localization of the SARS-CoV Accessory Proteins 7a and 7b (2006) (22)
- ECG changes after rabbit coronavirus infection☆ (1999) (22)
- A simulation framework to investigate in vitro viral infection dynamics (2011) (21)
- Specific mutations in H5N1 mainly impact the magnitude and velocity of the host response in mice (2013) (20)
- Efficient Reverse Genetic Systems for Rapid Genetic Manipulation of Emergent and Preemergent Infectious Coronaviruses (2017) (20)
- Reduced synthesis of Sindbis virus negative strand RNA in cultures treated with host transcription inhibitors (1983) (20)
- Role of Zika Virus Envelope Protein Domain III as a Target of Human Neutralizing Antibodies (2019) (20)
- Longitudinal analysis of acute and convalescent B cell responses in a human primary dengue serotype 2 infection model (2019) (20)
- SARS-CoV-2 mRNA vaccine induces robust specific and cross-reactive IgG and unequal neutralizing antibodies in naive and previously infected people (2022) (20)
- Transplantation of a quaternary structure neutralizing antibody epitope from dengue virus serotype 3 into serotype 4 (2017) (20)
- SARS-Like Coronavirus WIV1-CoV Does Not Replicate in Egyptian Fruit Bats (Rousettus aegyptiacus) (2018) (20)
- Bat Caliciviruses and Human Noroviruses Are Antigenically Similar and Have Overlapping Histo-Blood Group Antigen Binding Profiles (2018) (19)
- Analyzing the Human Serum Antibody Responses to a Live Attenuated Tetravalent Dengue Vaccine Candidate (2018) (19)
- SARS-CoV-2 vaccines elicit durable immune responses in infant rhesus macaques (2021) (19)
- A spike-modified Middle East respiratory syndrome coronavirus (MERS-CoV) infectious clone elicits mild respiratory disease in infected rhesus macaques (2018) (19)
- Prevention and therapy of SARS-CoV-2 and the B.1.351 variant in mice (2021) (19)
- A Novel Mutation in Murine Hepatitis Virus nsp5, the Viral 3C-Like Proteinase, Causes Temperature-Sensitive Defects in Viral Growth and Protein Processing (2008) (18)
- Bayesian Diallel Analysis Reveals Mx1-Dependent and Mx1-Independent Effects on Response to Influenza A Virus in Mice (2017) (18)
- SARS Coronavirus 3b Accessory Protein Modulates Transcriptional Activity of RUNX1b (2012) (18)
- Genetic complementation among three panels of mouse hepatitis virus gene 1 mutants. (1998) (18)
- Next-Generation High-Throughput Functional Annotation of Microbial Genomes (2016) (18)
- SARS-CoV-2 infection produces chronic pulmonary epithelial and immune cell dysfunction with fibrosis in mice (2022) (18)
- A Chimeric Virus-Mouse Model System for Evaluating the Function and Inhibition of Papain-Like Proteases of Emerging Coronaviruses (2014) (18)
- The mechanism of differential neutralization of dengue serotype 3 strains by monoclonal antibody 8A1. (2013) (18)
- Genome-wide bidirectional CRISPR screens identify mucins as host factors modulating SARS-CoV-2 infection (2022) (18)
- The Molecular Specificity of the Human Antibody Response to Dengue Virus Infections. (2018) (17)
- Virus-receptor interactions and interspecies transfer of a mouse hepatitis virus. (1998) (17)
- Sars Coronavirus Vaccine Development (2006) (17)
- Reverse Genetic Analysis of the Transcription Regulatory Sequence of the Coronavirus Transmissible Gastroenteritis Virus (2004) (17)
- Mucin 4 Protects Female Mice from Coronavirus Pathogenesis (2020) (17)
- Durability of Heterologous and Homologous COVID-19 Vaccine Boosts (2022) (17)
- Virus–Host Interactions Between Nonsecretors and Human Norovirus (2020) (17)
- Repurposing the Ebola and Marburg Virus Inhibitors Tilorone, Quinacrine and Pyronaridine: In vitro Activity Against SARS-CoV-2 and Potential Mechanisms (2020) (17)
- Identification of Dengue Virus Serotype 3 Specific Antigenic Sites Targeted by Neutralizing Human Antibodies. (2020) (16)
- Beyond Neutralizing Antibody Levels: The Epitope Specificity of Antibodies Induced by National Institutes of Health Monovalent Dengue Virus Vaccines (2019) (16)
- Modeling pathogenesis of emergent and pre-emergent human coronaviruses in mice (2018) (16)
- Sars Coronavirus Accessory ORFs Encode Luxury Functions (2006) (16)
- CD-loop Extension in Zika Virus Envelope Protein Key for Stability and Pathogenesis (2017) (16)
- Broadly neutralizing anti-S2 antibodies protect against all three human betacoronaviruses that cause severe disease (2022) (16)
- SARS-CoV: Lessons for global health (2007) (16)
- Preadaptation of pandemic GII.4 noroviruses in unsampled virus reservoirs years before emergence (2020) (16)
- Complex Genetic Architecture Underlies Regulation of Influenza-A-Virus-Specific Antibody Responses in the Collaborative Cross (2020) (16)
- Breadth of SARS-CoV-2 Neutralization and Protection Induced by a Nanoparticle Vaccine (2022) (15)
- Rapid selection of a human monoclonal antibody that potently neutralizes SARS-CoV-2 in two animal models (2020) (15)
- Facile discovery of surrogate cytokine agonists (2022) (15)
- The Role of EGFR in Influenza Pathogenicity: Multiple Network-Based Approaches to Identify a Key Regulator of Non-lethal Infections (2019) (15)
- Increasing the translation of mouse models of MERS coronavirus pathogenesis through kinetic hematological analysis (2019) (15)
- An Engineered Antibody with Broad Protective Efficacy in Murine Models of SARS and COVID-19 (2020) (15)
- A simian hemorrhagic fever virus isolate from persistently infected baboons efficiently induces hemorrhagic fever disease in Japanese macaques (2014) (15)
- Defining levels of dengue virus serotype-specific neutralizing antibodies induced by a live attenuated tetravalent dengue vaccine (TAK-003) (2020) (15)
- Epitope Addition and Ablation via Manipulation of a Dengue Virus Serotype 1 Infectious Clone (2017) (14)
- Impact of Pre-exposure History and Host Genetics on Antibody Avidity Following Norovirus Vaccination (2017) (14)
- Baseline T cell immune phenotypes predict virologic and disease control upon SARS-CoV infection in Collaborative Cross mice. (2021) (14)
- Identifying protective host gene expression signatures within the spleen during West Nile virus infection in the collaborative cross model (2016) (14)
- Dengue Vaccines: The Promise and Pitfalls of Antibody-Mediated Protection. (2021) (14)
- Genetic Dissection of the Regulatory Mechanisms of Ace2 in the Infected Mouse Lung (2021) (13)
- Non-Hodgkin lymphoma (NHL) subtypes defined by common translocations: utility of fluorescence in situ hybridization (FISH) in a case-control study. (2010) (13)
- Thiol-based chemical probes exhibit antiviral activity against SARS-CoV-2 via allosteric disulfide disruption in the spike glycoprotein (2022) (13)
- Each of the eight simian hemorrhagic fever virus minor structural proteins is functionally important. (2014) (13)
- Acute SARS-CoV-2 Infection is Highly Cytopathic, Elicits a Robust Innate Immune Response and is Efficiently Prevented by EIDD-2801 (2020) (13)
- Systems approaches to coronavirus pathogenesis (2014) (13)
- Analysis of Individuals from a Dengue-Endemic Region Helps Define the Footprint and Repertoire of Antibodies Targeting Dengue Virus 3 Type-Specific Epitopes (2017) (13)
- Secretor status strongly influences the incidence of symptomatic norovirus infection in a genotype-dependent manner in a Nicaraguan birth cohort. (2021) (12)
- Correction: Corrigendum: A SARS-like cluster of circulating bat coronaviruses shows potential for human emergence (2016) (12)
- Immune Predictors of Mortality After Ribonucleic Acid Virus Infection (2019) (12)
- Therapeutic efficacy of an oral nucleoside analog of remdesivir against SARS-CoV-2 pathogenesis in mice. (2021) (12)
- STAT5: a Target of Antagonism by Neurotropic Flaviviruses (2019) (12)
- Predicted norovirus resurgence in 2021–2022 due to the relaxation of nonpharmaceutical interventions associated with COVID-19 restrictions in England: a mathematical modeling study (2021) (11)
- SARS-CoV-2 Vaccines Elicit Durable Immune Responses in Infant Rhesus Macaques (2021) (11)
- Novel modulators of p53-signaling encoded by unknown genes of emerging viruses (2021) (11)
- Fc-engineered antibody therapeutics with improved efficacy against COVID-19 (2021) (11)
- Newcastle disease virus (NDV) expressing the spike protein of SARS-CoV-2 as vaccine candidate (2020) (11)
- Resolution of diarrhea in an immunocompromised patient with chronic norovirus gastroenteritis correlates with constitution of specific antibody blockade titer (2016) (11)
- IN VITRO SELECTION OF AN ATTENUATED VARIANT OF SINDBIS VIRUS (1982) (11)
- A model of persistent post SARS-CoV-2 induced lung disease for target identification and testing of therapeutic strategies (2022) (11)
- Protective efficacy of rhesus adenovirus COVID-19 vaccines against mouse-adapted SARS-CoV-2 (2021) (10)
- Unfolded Protein Response Inhibition Reduces Middle East Respiratory Syndrome Coronavirus-Induced Acute Lung Injury (2021) (10)
- Studies into the mechanism for MHV transcription. (1993) (10)
- Studies on the mechanism of RNA synthesis of a murine coronavirus. (1984) (9)
- Author Correction: A SARS-like cluster of circulating bat coronaviruses shows potential for human emergence (2020) (9)
- Human biliary glycoproteins function as receptors for interspecies transfer of mouse hepatitis virus. (1998) (9)
- Correction: SARS Coronavirus 3b Accessory Protein Modulates Transcriptional Activity of RUNX1b (2012) (9)
- A case–control study of tobacco use and other non-occupational risk factors for lymphoma subtypes defined by t(14; 18) translocations and bcl-2 expression (2010) (9)
- Transcriptional profiles of WNV neurovirulence in a genetically diverse Collaborative Cross population (2016) (9)
- Publisher Correction: Single-shot Ad26 vaccine protects against SARS-CoV-2 in rhesus macaques (2021) (9)
- Erratum: Vaccine efficacy in senescent mice challenged with recombinant SARS-CoV bearing epidemic and zoonotic spike variants (PLoS Medicine 3,12 DOI: 10.1371/journal.pmed.0030525) (2007) (9)
- CC002/Unc females are mouse models of exercise‐induced paradoxical fat response (2018) (8)
- Reply to “Statins may decrease the Fatality Rate of MERS Infection” (2015) (8)
- Dengue virus envelope protein domain I/II hinge: a key target for dengue virus vaccine design? (2015) (8)
- Production and Clinical Evaluation of Norwalk GI.1 Virus Lot 001-09NV in Norovirus Vaccine Development (2019) (8)
- Humanized mice develop coronavirus respiratory disease. (2005) (8)
- Content and Performance of the MiniMUGA Genotyping Array: A New Tool To Improve Rigor and Reproducibility in Mouse Research. (2020) (8)
- Dengue vaccine breakthrough infections reveal properties of neutralizing antibodies linked to protection. (2021) (8)
- Association between herpes simplex virus type 1 and Helicobacter pylori in US adolescents. (2006) (8)
- Receptor homologue scanning functions in the maintenance of MHV-A59 persistence in vitro. (1998) (8)
- Resurrection of an “Extinct” SARS-CoV Isolate GD03 from LATE 2003 (2006) (7)
- A Multitrait Locus Regulates Sarbecovirus Pathogenesis (2022) (7)
- Bile Facilitates Human Norovirus Interactions with Diverse Histoblood Group Antigens, Compensating for Capsid Microvariation Observed in 2016–2017 GII.2 Strains (2020) (7)
- Cross-reactive coronavirus antibodies with diverse epitope specificities and extra-neutralization functions (2020) (7)
- Sars Cov Replication and Pathogenesis in Human Airway Airway Epithelial Cultures (2006) (7)
- Serological Humoral Immunity Following Natural Infection of Children with High Burden Gastrointestinal Viruses (2021) (7)
- The Human Sodium Iodide Symporter as a Reporter Gene for Studying Middle East Respiratory Syndrome Coronavirus Pathogenesis (2018) (7)
- Co-administration of Favipiravir and the Remdesivir Metabolite GS-441524 Effectively Reduces SARS-CoV-2 Replication in the Lungs of the Syrian Hamster Model (2022) (7)
- Ex vivo and in vivo suppression of SARS-CoV-2 with combinatorial AAV/RNAi expression vectors (2022) (7)
- SARS-CoV-2 vaccination induces neutralizing antibodies against pandemic and pre-emergent SARS-related coronaviruses in monkeys (2021) (7)
- Systematic Assembly and Genetic Manipulation of the Mouse Hepatitis Virus A59 Genome (2007) (7)
- Human Norovirus Histo-Blood Group Antigen (HBGA) Binding Sites Mediate the Virus Specific Interactions with Lettuce Carbohydrates (2019) (7)
- SARS-like cluster of circulating bat coronavirus pose threat for human emergence (2016) (7)
- Norovirus-Specific CD8+ T Cell Responses in Human Blood and Tissues (2021) (6)
- Renilla Luciferase as a Reporter to Assess SARS-CoV mRNA Transcription Regulation and Efficacy of ANTI-SARS-CoV Agents (2006) (6)
- Early therapy with remdesivir and antibody combinations improves COVID-19 disease in mice (2021) (6)
- A newly identified MHV-A59 ORF1a polypeptide p65 is temperature sensitive in two RNA negative mutants. (1993) (6)
- Sex Disparities and Neutralizing-Antibody Durability to SARS-CoV-2 Infection in Convalescent Individuals (2021) (6)
- Critical ACE2 Determinants of SARS-CoV-2 and Group 2B Coronavirus Infection and Replication (2021) (6)
- Correction: Vaccine Efficacy in Senescent Mice Challenged with Recombinant SARS-CoV Bearing Epidemic and Zoonotic Spike Variants (2007) (6)
- An effective DNA vaccine platform for Middle East respiratory syndrome coronavirus. (2016) (6)
- A Simulation Framework to Investigate in vitro Viral Infection Dynamics (2011) (6)
- Broad-spectrum Investigational Agent GS-5734 for the Treatment of Ebola, MERS Coronavirus and Other Pathogenic Viral Infections with High Outbreak Potential (2017) (6)
- MHV-A59 Orf1a Replicase Protein NSP7-NSP10 Processing in Replication (2006) (6)
- Genomewide CRISPR knockout screen identified PLAC8 as an essential factor for SADS-CoVs infection (2022) (6)
- A Reverse genetics system for dsRNA viruses. (2007) (6)
- De novo design of ACE2 protein decoys to neutralize SARS-CoV-2 (2020) (6)
- Correction: In-Depth Analysis of the Antibody Response of Individuals Exposed to Primary Dengue Virus Infection (2011) (5)
- Is regulation preventing the development of therapeutics that may prevent future coronavirus pandemics? (2018) (5)
- Retraction: Dengue virus envelope protein domain I/II hinge determines long-lived serotype-specific dengue immunity (Proc Natl Acad Sci USA (2014) 111, (1939-1944) DOI: 10.1073/pnas.1317350111) (2015) (5)
- Echocardiographic changes following rabbit coronavirus infection. (1995) (5)
- Identification of Cross-reactive 1 Norovirus CD 4 + T Cell Epitopes 2 3 (2010) (5)
- A single intranasal dose of chimpanzee adenovirus-vectored vaccine confers sterilizing immunity against SARS-CoV-2 infection (2020) (5)
- Genetics and Reverse Genetics of Nidoviruses (2008) (5)
- Prevalence and Mechanisms of Mucus Accumulation in COVID-19 Lung Disease (2022) (5)
- Shortening of Zika virus CD-loop reduces neurovirulence while preserving antigenicity (2019) (5)
- Impact of Pre-exposure History and Host Genetics on Antibody Avidity Following Norovirus Vaccination. (2017) (5)
- Distinct genetic determinants and mechanisms of SARS-CoV-2 resistance to remdesivir (2022) (5)
- Tracking the polyclonal neutralizing antibody response to a dengue virus serotype 1 type-specific epitope across two populations in Asia and the Americas (2019) (5)
- Ethnoracial Disparities in SARS-CoV-2 Seroprevalence in a Large Cohort of Individuals in Central North Carolina from April to December 2020 (2022) (4)
- Trypsin treatment unlocks barrier for zoonotic coronaviruses infection (2019) (4)
- Publisher Correction: A mouse-adapted model of SARS-CoV-2 to test COVID-19 countermeasures (2021) (4)
- SARS Coronavirus 3 b Accessory Protein Modulates Transcriptional Activity of RUNX 1 b (2011) (4)
- Murine coronavirus temperature sensitive mutants. (1990) (4)
- Predicted Norovirus Resurgence in 2021–2022 Due to the Relaxation of Nonpharmaceutical Interventions Associated with COVID-19 Restrictions in England: A Mathematical Modelling Study (2021) (4)
- Broadly neutralizing anti-S2 antibodies protect against all three human betacoronaviruses that cause deadly disease (2023) (4)
- Outcomes of convalescent plasma with defined high- versus lower-neutralizing antibody titers against SARS-CoV-2 among hospitalized patients: CoronaVirus Inactivating Plasma (CoVIP), double-blind phase 2 study. (2022) (4)
- Outcomes of Convalescent Plasma with Defined High versus Lower Neutralizing Antibody Titers against SARS-CoV-2 among Hospitalized Patients: CoronaVirus Inactivating Plasma (CoVIP) Study (2022) (4)
- Thiol-based mucolytics exhibit antiviral activity against SARS-CoV-2 through allosteric disulfide disruption in the spike glycoprotein (2021) (4)
- Protective Efficacy of Rhesus Adenovirus COVID-19 Vaccines against Mouse-Adapted SARS-CoV-2 (2021) (4)
- Conserved coronavirus proteins as targets of broad-spectrum antivirals (2022) (3)
- Mission, Organization, and Future Direction of the Serological Sciences Network for COVID-19 (SeroNet) Epidemiologic Cohort Studies (2022) (3)
- Erratum: A SARS-like cluster of circulating bat coronaviruses shows potential for human emergence (Nature Medicine(2015) DOI: 10.1038/nm.3985) (2016) (3)
- MHV subgenomic negative strand function. (2001) (3)
- Progenitor identification and SARS-CoV-2 infection in human distal lung organoids (2020) (3)
- Two mutations were critical for bat-to-human transmission of MERS coronavirus 1 2 (2015) (3)
- A SARS-like cluster of circulating bat coronaviruses shows potential for human emergence (2015) (3)
- Studies into the mechanism of MHV transcription. (1987) (3)
- Clonal replacement sustains long-lived germinal centers primed by respiratory viruses (2022) (3)
- Human lung organoids as a model for respiratory virus replication and countermeasure performance in human hosts. (2022) (3)
- Detection of enteroviruses in shellfish by fluorogenic polymerase chain reaction integrated with 96-well microplate scanning. (2002) (3)
- Unified feature association networks through integration of transcriptomic and proteomic data (2019) (3)
- Host Kinase CSNK2 is a Target for Inhibition of Pathogenic SARS-like β-Coronaviruses (2022) (3)
- Detection of Hepatitis A Virus and Other Enteroviruses in Environmental Samples Using Gene Probe Methods (1990) (3)
- Vaccines for Severe Acute Respiratory Syndrome Virus and Other Coronaviruses (2008) (3)
- Infectious Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Virus in Symptomatic Coronavirus Disease 2019 (COVID-19) Outpatients: Host, Disease, and Viral Correlates. (2021) (3)
- Allelic variation in mouse Ticam2 contributes to SARS-CoV pathogenesis (2017) (3)
- Disulfide stabilization of human norovirus GI.1 virus-like particles focuses immune response toward blockade epitopes (2020) (3)
- Immune Imprinting Drives Human Norovirus Potential for Global Spread (2022) (3)
- Synthetic Viral Genomics: Risks and Benefits for Science and Society (2007) (3)
- Altered proteolytic processing of the polymerase polyprotein in RNA(-) temperature sensitive mutants of murine coronavirus. (1993) (2)
- Breadth and Dynamics of Human Norovirus-Specific Antibodies in the First Year of Life (2022) (2)
- Fc mediated pan-sarbecovirus protection after alphavirus vector vaccination (2022) (2)
- Spike Gene Determinants of Mouse Hepatitis Virus Host Range Expansion (2006) (2)
- Fcγ receptor-dependent antibody effector functions are required for vaccine protection against infection by antigenic variants of SARS-CoV-2 (2022) (2)
- Vandetanib Reduces Inflammatory Cytokines and Ameliorates COVID-19 in Infected Mice (2021) (2)
- mRNA DISPLAY DESIGN OF FIBRONECTIN-BASED INTRABODIES THAT DETECT AND INHIBIT SARS-COV N PROTEIN (2009) (2)
- SARS-CoV-2 mRNA Vaccine Induces Robust Specific and Cross-reactive IgG and Unequal Strain-specific Neutralizing Antibodies in Naïve and Previously Infected Recipients (2021) (2)
- Rabbit dilated cardiomyopathy. (1990) (2)
- Evidence that MHV subgenomic negative strands are functional templates. (1995) (2)
- A simple strategy to assemble infectious RNA and DNA clones. (2001) (2)
- SARS Coronavirus Pathogenesis and Therapeutic Treatment Design (2009) (2)
- Mutational Analysis of MHV-A59 Replicase Protein-NSP10 (2006) (2)
- Antigenic Site Immunodominance Redirection Following Repeat Variant Exposure (2022) (2)
- Infectious SARS-CoV-2 Virus in Symptomatic COVID-19 Outpatients: Host, Disease, and Viral Correlates (2021) (2)
- Mouse Adapted SARS-CoV-2 (MA10) Viral Infection Induces Neuroinflammation in Standard Laboratory Mice (2022) (2)
- Genetically Engineered DENV Produces Antigenically Distinct Mature Particles (2021) (2)
- Chapter 13 Host Genetics It Is Not Just the Virus, Stupid (2016) (2)
- Generation of Mature DENVs via Genetic Modification and Directed Evolution (2022) (2)
- Primer ID Next-Generation Sequencing for the Analysis of a Broad Spectrum Antiviral Induced Transition Mutations and Errors Rates in a Coronavirus Genome. (2021) (2)
- Preadaptation of pandemic GII.4 noroviruses in hidden virus reservoirs years before emergence (2019) (2)
- Evolution and persistence mechanisms of mouse hepatitis virus. (1995) (2)
- Erratum for Markmann et al., “Sex Disparities and Neutralizing-Antibody Durability to SARS-CoV-2 Infection in Convalescent Individuals” (2021) (2)
- Multivalent S2-based vaccines provide broad protection against SARS-CoV-2 variants of concern and pangolin coronaviruses (2022) (2)
- Pharmacokinetic‐based failure of a detergent virucidal for severe acute respiratory syndrome–coronavirus‐2 (SARS‐CoV‐2) nasal infections: A preclinical study and randomized controlled trial (2022) (2)
- 42 – Norovirus Vaccines (2018) (1)
- A luciferase-based approach for measuring HBGA blockade antibody titers against human norovirus. (2021) (1)
- Infant rhesus macaques immunized against SARS-CoV-2 are protected against heterologous virus challenge one year later (2022) (1)
- Therapeutic Potential of SARS-CoV-2-Specific Monoclonal Antibody CR3022 (2020) (1)
- Association between herpes simplex virus type 1 and Helicobacter Pylori (2004) (1)
- A live dengue virus vaccine carrying a chimeric envelope glycoprotein elicits dual DENV2-DENV4 serotype-specific immunity (2023) (1)
- Transmission of viral pathogens in a social network of university students: the eX-FLU study (2020) (1)
- Corrigendum to "Each of the eight simian hemorrhagic fever virus minor structural proteins is functionally important" [Virology 462-463 (2014) 351-362]. (2014) (1)
- Common Mechanism of SARS-CoV and SARS-CoV-2 Pathogenesis across Species (2021) (1)
- Baseline T cell immune phenotypes predict virologic and disease control upon SARS-CoV infection (2020) (1)
- IgG-like bispecific antibodies with potent and synergistic neutralization against circulating SARS-CoV-2 variants of concern (2022) (1)
- PLOS Pathogens 2016 Reviewer and Editorial Board Thank You (2017) (1)
- SARS-CoV-2 infectious virus, viral RNA in nasopharyngeal swabs, and serostatus of symptomatic COVID-19 outpatients in the United States (2021) (1)
- Genetic regulation of homeostatic immune architecture in the lungs of Collaborative Cross mice (2021) (1)
- MERS-CoV NSP16 necessary for IFN resistance and viral pathogenesis (2017) (1)
- Retraction for Messer et al., Dengue virus envelope protein domain I/II hinge determines long-lived serotype-specific dengue immunity (2015) (1)
- Evaluation of a COVID-19 convalescent plasma program at a U.S. academic medical center (2022) (1)
- Modeling pathogenesis of emergent and pre-emergent human coronaviruses in mice (2018) (1)
- Host kinase CSNK2 is a target for inhibition of pathogenic β-coronaviruses including SARS-CoV-2 (2022) (1)
- Newcastle disease virus ( NDV ) expressing the spike protein of SARS-CoV-2 as vaccine candidate 1 2 (2020) (1)
- Vandetanib Blocks the Cytokine Storm in SARS-CoV-2-Infected Mice (2022) (1)
- Diallel analysis reveals Mx1-dependent and Mx1-independent effects on response to influenza A virus in mice (2017) (1)
- P115 Pathogenic Influenza A viruses and SARS-Coronaviruses modulate global interferon stimulated gene induction through diverse mechanisms (2012) (1)
- Single-shot Ad26 vaccine protects against SARS-CoV-2 in rhesus macaques (2020) (0)
- Evaluation of a recombination-resistant coronavirus as a broadly applicable, rapidly implementable vaccine platform (2018) (0)
- of from a Region Helps Define the Footprint and Repertoire of Antibodies Targeting Dengue Virus 3 Type-Specific Epitopes. (2017) (0)
- Cell Host & Microbe Resource An Immunocompetent Mouse Model of Zika Virus Infection (2018) (0)
- Is SARS-CoV-2 a Product of Reverse Genetics Using Vaccinia Virus-Based Recombination? (2021) (0)
- The COVID-19 outbreak: an update on the SARS-CoV-2 virus (2020) (0)
- Differential serological immune imprinting following SARS-CoV-2 infection, vaccination, and breakthrough infection (2022) (0)
- Respiratory Syndrome Coronavirus Domain from Newly Emerged Middle East Crystal Structure of the Receptor-Binding (2013) (0)
- 1-O-Octadecyl-2-O-benzyl-sn-glyceryl-3-phospho-GS-441524 (V2043). Evaluation of Oral V2043 in a Mouse Model of SARS-CoV-2 Infection and Synthesis and Antiviral Evaluation of Additional Phospholipid Esters with Enhanced Anti-SARS-CoV-2 Activity (2023) (0)
- Phylogenic Reconstruction of the GII.4 Shell Domain and P1 and P2 Subdomains (2008) (0)
- Norovirus vaccine induces a cross-genotype protective immune response (2020) (0)
- Role in Escape from Human Herd Immunity Potential Norovirus GII.4 Blockade Epitope: Genetic Mapping of a Highly Variable (2012) (0)
- Dose-Response of a Norovirus GII.2 Controlled Human Challenge Model Inoculum. (2022) (0)
- Dynamics of SARS-CoV-2 VOC Neutralization and Novel mAb Reveal Protection against Omicron (2023) (0)
- SARS-CoV-2 mRNA vaccine design enabled by prototype pathogen preparedness Preview (2020) (0)
- Optimization of non-coding regions for a non-modified mRNA COVID-19 vaccine (2021) (0)
- 1 Particle Conformation Regulates Antibody Access to a Conserved GII . 4 Norovirus 1 Blockade Epitope . 2 3 (2014) (0)
- Targeting Spike Glycans to Inhibit SARS-CoV2 Viral Entry (2022) (0)
- COVID-19 epidemiology and potential treatments: follow up interview (2020) (0)
- A research and development (R&D) roadmap for broadly protective coronavirus vaccines: A pandemic preparedness strategy (2023) (0)
- It Is Not Just the Virus, Stupid (0)
- Corrigendum to ‘‘Longitudinal analysis of acute and convalescent B cell responses in a human primary dengue serotype 2 infection model’’ [EBioMedicine 41 (2019) 465–478] (2020) (0)
- Developing broadly protective strategies to protect against future pandemic threats (2022) (0)
- Severe acute respiratory coronavirus: SARS-CoV (2007) (0)
- Metatranscriptomics analysis reveals a novel transcriptional and translational landscape during Middle East Respiratory Syndrome Coronavirus infection (2023) (0)
- Acknowledgment to reviewers (2018) (0)
- Genetic regulation of immune homeostatic lung leukocyte populations (2020) (0)
- Norovirus Infection in Young Nicaraguan Children Induces Durable and Genotype-Specific Antibody Immunity (2022) (0)
- Pharmacokinetic-based failure of a detergent virucidal for SARS-COV-2 nasal infections (2021) (0)
- Cryo-electron microscopy structure of mouse coronavirus spike protein complexed with its murine receptor (2020) (0)
- Human Norovirus Infection: Genetic and Immune Determinants of Susceptibility and Resistance (2007) (0)
- Monoclonal Antibody-Based Antigenic (2013) (0)
- Evolution of a Functionally Intact but Antigenically Distinct DENV Fusion Loop (2023) (0)
- Potent Neutralization of Omicron and other SARS-CoV-2 Variants of Concern by Biparatopic Human VH Domains (2022) (0)
- hepatitis virus. in the mRNA of mouse Presence of leader sequences (2013) (0)
- Norovirus molecular biology, immunity and vaccines. (2008) (0)
- Retraction for hinge determines (2015) (0)
- A mouse-adapted model of SARS-CoV-2 to test COVID-19 countermeasures (2020) (0)
- Precision mouse models with expanded tropism for human pathogens (2019) (0)
- Preexisting Heterotypic Ligand-blocking Antibody Does Not Protect Against Genogroup II Norovirus Episodes in Young Children. (2022) (0)
- Novel Influenza Virus NS1 Antagonists Block Replication and Restore Innate Immune Function (cid:1) † (2009) (0)
- Broadly Blocking Immune Responses Virus-Like-Particle-Based Vaccines Induce Chimeric GII . 4 Norovirus (2014) (0)
- Coronavirus Immunotherapeutic Consortium Database (2023) (0)
- Cytokine systems approach demonstrates differences in innate and pro-inflammatory host responses between genetically distinct MERS-CoV isolates (2014) (0)
- Effect of Mutations in the Mouse Hepatitis Virus 3 (cid:2) ( (cid:1) )42 Protein Binding Element on RNA Replication (2005) (0)
- Fc-γR-dependent antibody effector functions are required for vaccine-mediated protection against antigen-shifted variants of SARS-CoV-2 (2023) (0)
- Potent and broad neutralization of SARS-CoV-2 variants of concern (VOCs) including omicron sub-lineages BA.1 and BA.2 by biparatopic human VH domains (2022) (0)
- Genetics ofMouseHepatitis Virus Transcription: Evidence that Subgenomic Negative Strands AreFunctional Templates (1994) (0)
- Immunogenicity and protective efficacy of a rhesus adenoviral vaccine targeting conserved COVID-19 replication transcription complex (2022) (0)
- Fc-mediated pan-sarbecovirus protection after alphavirus vector vaccination (2023) (0)
- Extremely potent pan-sarbecovirus neutralizing antibodies generated by immunization of macaques with an AS03-adjuvanted monovalent subunit vaccine against SARS-CoV-2 (2023) (0)
- Pulmonary Fibroproliferative Response in Old Mice That Survive Acute Lung Injury by Mouse-Adapted SARS-CoV-2 (2021) (0)
- Predictors of human norovirus infection and immunity (133.52) (2009) (0)
- Human ACE2 expression, a major tropism determinant for SARS-CoV-2, is regulated by upstream and intragenic elements (2023) (0)
- The Open Reading Frame 3a Protein of Severe Acute Respiratory Syndrome-Associated Coronavirus Promotes Membrane Rearrangement and Cell Death (cid:1) ‡ (2009) (0)
- Emergent variant modeling of the serological repertoire to norovirus in young children (2023) (0)
- In Vitro Assembly and Stabilization of Dengue and Zika Virus Envelope Protein Homo-Dimers (2017) (0)
- Host network-based discovery of critical regulators of innate immunity, virus growth, and pathogenesis in influenza virus infection (2022) (0)
- Predictors of human norovirus infection and immunity (2009) (0)
- POTENTIALL Y IMPORTANT EMERGING VIRUSES (2011) (0)
- Abstract 1509: Targeting Spike Glycans to Inhibit SARS-CoV-2 Viral Entry (2023) (0)
- Cryo-EM structure of zika virus complexed with Fab C10 at pH 8.0 (2016) (0)
- A novel mouse model of SARS‐CoV‐2 induced neuroinflammation (2022) (0)
- A C57BL/6 Mouse model of SARS-CoV-2 infection recapitulates age- and sex-based differences in human COVID-19 disease and recovery (2022) (0)
- SARS-CoV-2 Spike triggers barrier dysfunction and vascular leak via integrins and TGF-β signaling (2022) (0)
- Breadth of SARS-CoV-2 neutralization and protection induced by a nanoparticle vaccine (2022) (0)
- Increased Antibody Affinity Confers Broad In Vitro Protection against Escape Mutants of Severe Acute Respiratory Syndrome Coronavirus (2012) (0)
- Universal Immune Predictors of Mortality Following Virus Infection (2019) (0)
- Immunity and Natural Resistance to Norovirus Infection (2015) (0)
- A spike-modified Middle East respiratory syndrome coronavirus (MERS-CoV) infectious clone elicits mild respiratory disease in infected rhesus macaques (2018) (0)
- SARS-CoV-2 antibodies specific to the mesa and inner side of spike protein receptor binding domain maintain high affinities for both D614G and b.1.351 variants (2022) (0)
- Zika virus infection in Collaborative Cross mice (2019) (0)
- Disulfide stabilization of human norovirus GI.1 virus-like particles focuses immune response toward blockade epitopes (2020) (0)
- Vaccine-induced antibodies to contemporary strains of dengue virus type 4 show a mechanistic correlate of protective immunity. (2022) (0)
- Longitudinal Analysis of Humoral and Cellular Immune Response Following SARS-CoV-2 Vaccination Supports Utilizing Point-Of-Care Tests to Enhance COVID-19 Booster Uptake. (2023) (0)
- Publisher Correction: A mouse-adapted model of SARS-CoV-2 to test COVID-19 countermeasures (2021) (0)
- Efficacy of pediatric SARS-CoV-2 vaccines against high-dose B.1.617.2 challenge one year after vaccination of infant rhesus macaques (2022) (0)
- Cross Genetic analysis of complex traits in the emerging Collaborative Material Supplemental (2011) (0)
- Insulin-Like Growth Factor I Polymorphisms in Breast Cancer (2002) (0)
- P-153: Feasibility of Serial Saliva Collection for Surveillance of Swimming- Associated Illness (2012) (0)
- SARS-CoV and other emerging coronaviruses (2018) (0)
- Dynamics of SARS-CoV-2 VOC neutralization and novel mAb reveal protection against Omicron (2022) (0)
- A Multitrait Locus Regulates Sarbecovirus Pathogenesis (2022) (0)
- Abstract P35: Targeting vimentin impacts multiple cellular processes, blocks the spike protein-ACE2-mediated pseudoviral infection in vitro and reduces the symptom and lung injury in aged mice with mouse-adapted SARS-CoV-2 infection in vivo (2021) (0)
- SARS-CoV-2 mRNA vaccine design enabled by prototype pathogen preparedness (2020) (0)
- Nanoparticle display of prefusion coronavirus spike elicits S1-focused cross-reactive protection across divergent subgroups (2022) (0)
- Running Title: A Full-length Infectious Clone of NL63 2 (2008) (0)
- 1 Development of a Broadly Accessible VEE Replicon Particle Vaccine Platform (2018) (0)
- Crystal Structure of SARS-CoV nsp9 G104E (2009) (0)
- A C57BL/6 Mouse Model of SARS-CoV-2 Infection Recapitulates Age- and Sex-Based Differences in Human COVID-19 Disease and Recovery (2022) (0)
- A global map of the Zika virus phosphoproteome reveals host-driven regulation of viral budding (2021) (0)
- RNA SYNTHESIS OF A MURINE CORONA VIRUS (1984) (0)
- Targeted isolation of diverse human protective broadly neutralizing antibodies against SARS-like viruses (2022) (0)
- Additional file 6: of The effect of inhibition of PP1 and TNFÎą signaling on pathogenesis of SARS coronavirus (2016) (0)
- Mouse Adapted SARS‐CoV‐2 induces ‘long‐COVID’ neuropathology in BALB/c mice (2022) (0)
- Mouse Adapted SARS-CoV-2 Model Induces “Long-COVID” Neuropathology in BALB/c Mice (2023) (0)
- Animal models for COVID-19 (2020) (0)
- Transplantation of a quaternary structure neutralizing antibody epitope from dengue virus serotype 3 into serotype 4 (2017) (0)
- Severe Acute Respiratory Syndrome Coronavirus Papain-Like Protease Ubiquitin-Like Domain and Catalytic Domain Regulate Antagonism of IRF3 and NF- (cid:2) B Signaling (cid:1) † (2009) (0)
This paper list is powered by the following services:
Other Resources About Ralph S. Baric
What Schools Are Affiliated With Ralph S. Baric?
Ralph S. Baric is affiliated with the following schools:
